Massachusetts Financial Services CO Eli Lilly & CO Transaction History

Massachusetts Financial Services CO

$321 Billion
Q1 2024

A detailed history of Massachusetts Financial Services CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Massachusetts Financial Services CO holds 3,113,080 shares of LLY stock, worth $2.82 Billion. This represents 0.75% of its overall portfolio holdings.

Number of Shares

3,113,080

Previous 3,213,357 3.12%

Holding current value

$2.82 Billion

Previous $1.87 Billion 29.29%

% of portfolio

0.75%

Previous 0.63%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $59.4 Million - $79.4 Million	-100,277 Reduced 3.12%	3,113,080 $2.42 Billion
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $51.2 Million - $60.4 Million	-97,502 Reduced 2.94%	3,213,357 $1.87 Billion
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $281 Million - $387 Million	645,473 Added 24.22%	3,310,859 $1.78 Billion
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $587 Million - $784 Million	1,672,502 Added 168.45%	2,665,386 $1.25 Billion
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $23.5 Million - $27.6 Million	-75,724 Reduced 7.09%	992,884 $341 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $66.2 Million - $77.1 Million	-205,748 Reduced 16.15%	1,068,608 $391 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $32.4 Million - $36.9 Million	-109,138 Reduced 7.89%	1,274,356 $412 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $31.1 Million - $36.5 Million	-111,505 Reduced 7.46%	1,383,494 $449 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $25.2 Million - $31.4 Million	-107,545 Reduced 6.71%	1,494,999 $428 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $65.2 Million - $80.9 Million	-289,920 Reduced 15.32%	1,602,544 $443 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $64.8 Million - $79.7 Million	-292,327 Reduced 13.38%	1,892,464 $437 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $69.4 Million - $89.8 Million	-384,346 Reduced 14.96%	2,184,791 $501 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $130 Million - $168 Million	-790,114 Reduced 23.52%	2,569,137 $480 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $149 Million - $197 Million	-1,138,872 Reduced 25.32%	3,359,251 $567 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $51.8 Million - $60 Million	-354,538 Reduced 7.31%	4,498,123 $666 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $33.1 Million - $39.9 Million	-242,852 Reduced 4.77%	4,852,661 $797 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $114 Million - $141 Million	-954,817 Reduced 15.78%	5,095,513 $707 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $42 Million - $52 Million	-392,473 Reduced 6.09%	6,050,330 $795 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $67.1 Million - $73 Million	628,267 Added 10.81%	6,442,803 $720 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $73.2 Million - $85.4 Million	660,406 Added 12.81%	5,814,536 $644 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $60.6 Million - $71.4 Million	544,732 Added 11.82%	5,154,130 $669 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $10.7 Million - $12 Million	-101,408 Reduced 2.15%	4,609,398 $533 Million
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $219 Million - $274 Million	-2,553,321 Reduced 35.15%	4,710,806 $506 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $53.9 Million - $61.9 Million	-712,576 Reduced 8.93%	7,264,127 $620 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $31.5 Million - $37.2 Million	-424,122 Reduced 5.05%	7,976,703 $617 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $141 Million - $151 Million	-1,720,464 Reduced 17.0%	8,400,825 $710 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $4.09 Million - $4.54 Million	-53,026 Reduced 0.52%	10,121,289 $866 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,174,315	10,174,315 $837 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Eli Lilly & CO Transaction History